NovoCodex has been engaged in the business of genetic engineering, and cell culture, among others.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Mar 19, 2021 | Series A | ¥400M | 1 | Lilly Asia Ventures | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Lilly Asia Ventures | Yes | Series A |